版本:
中国

BRIEF-Reata Pharmaceuticals reports Q1 loss per share of $0.32

May 11 Reata Pharmaceuticals Inc

* Announces first quarter 2017 financial and operating results

* Q1 loss per share $0.32

* Q1 earnings per share view $-0.13 -- Thomson Reuters I/B/E/S

* Enrolling patients with PH-ILD caused by sarcoidosis, idiopathic pulmonary fibrosis, among others in Lariat trial in Cohort 4

* Anticipate that data from PH-ILD patients in Lariat will be available in second half of 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐